Terlipressin as Rescue Therapy in Catecholamine-Resistant Hypotension in Solid Organ Donors: A Case Report

Transplantation Proceedings

Volumn 42, Issue 1, 2010, Pages 203-205

  Vecchiarelli, P ^a   Ricci, F ^a   Riccini, T ^a  

^a BELCOLLE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; DESMOPRESSIN; HYDROCORTISONE; NORADRENALIN; TERLIPRESSIN;

AGED; ANURIA; ARTERIAL PRESSURE; ARTICLE; BRAIN DEATH; BRAIN HEMORRHAGE; CASE REPORT; CATECHOLAMINE RESISTANT HYPOTENSION; CORE TEMPERATURE; DIABETES INSIPIDUS; DRUG EFFECT; DRUG MEGADOSE; ELECTROENCEPHALOGRAM; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; HYPOTHERMIA; KIDNEY PERFUSION; LIVER PERFUSION; MALE; ORGAN DONOR; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; SALVAGE THERAPY; SEPTIC SHOCK; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; URINE OSMOLALITY; URINE VOLUME; WARMING;

ADULT; AGED; ANURIA; BLOOD PRESSURE; BRAIN DEATH; CEREBRAL HEMORRHAGE; DIURESIS; HEPATECTOMY; HUMANS; HYPOTENSION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LYPRESSIN; NEPHRECTOMY; TISSUE DONORS; VASOCONSTRICTOR AGENTS;

EID: 76749114246     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.12.010     Document Type: Article

References (23)

1. Power D.J., and Kellum J.A. Maintaining acid-base balance in organ donors. Prog Transplant 10 (2000) 98
2. Chen J.M., Cullinane S., Spanier T.B., et al. Vasopressin deficiency and pressor hypersensitivity in hemodynamically unstable organ donors. Circulation 100 (1999) II-244
3. Iwai A., Sakano T., Uenishi M., et al. Effects of vasopressin and catecholamines on the maintenance of circulatory stability in brain-dead patients. Transplantation 48 (1989) 613
4. Landry D.W., Levin H.R., Gallant E.M., et al. Vasopressin deficiency contributes to the vasodilatation of septic shock. Circulation 95 (1997) 1108
5. Zaroff J.G., Rosengard B.R., Armstrong W.F., et al. Consensus conference report. Maximizing use of organs recovered from the cadaver donor: cardiac recommendation. Circulation 106 (2002) 836
6. Yoshioka T., Sugimoto H., and Uenishi M. Prolonged hemodynamic maintenance by the combined administration of vasopressin and epinephrine in brain death: a clinical study. Neurosurgery 18 (2002) 565
7. Kinoshita Y., Okamoto K., Yahata K., et al. Clinical and pathological changes of the heart in brain death maintained with vasopressin and epinephrine. Pathol Res Pract 186 (1990) 173
8. Rodriguez-Perez F., and Groszmann R.J. Pharmacological treatment of portal hypertension. Gastroenterol Clin North Am 21 (1992) 15
9. Nilsson G., Lindblom P., Ohlin N., et al. Pharmacokinetics of terlipressin after single I.V. doses to healthy volunteers. Drugs Exp Clin Res 16 (1990) 307
10. O'Brien A., Clapp L., and Singer M. Terlipressin for norepinephrine-resistant septic shock. Lancet 359 (2000) 1209
11. Rodriguez-Nunes A., Fernandez-Sanmartin M., Martinon-Torres F., et al. Terlipressin for catecholamine-resistant septic shock in children. Intens Care Med 30 (2004) 477
12. Matok I., Vard A., Efrati O., et al. Terlipressin as rescue therapy for intractable hypotension due to septic shock in children. Shock 23 (2005) 305
13. Morelli A., Rocco M., Conti G., et al. Effects of terlipressin on systemic and regional haemodinamics in catecholamine-treated hyperkinetic septic shock. Intens Care Med 30 (2004) 597
14. Blasco V., Leone M., Geissler A., et al. Impact of terlipressin on renal graft function. Shock 29 (2008) 667
15. Mackersie R.C., Bronsther O.L., and Shanckford S.R. Organ procurement in patients with fatal head injuries. The fate of the potential donor. Ann Surg 213 (1991) 143
16. Huttemann E., Schelenz C., Chatzinikolaou K., et al. Left ventricular dysfunction in lethal severe brain injury: impact of transesophageal echocardiography on patient management. Intens Care Med 28 (2002) 1084
17. Wagner Jr. H.N., and Braunwald E. The pressor effect of the antidiuretic principle of the posterior pituitary in orthostatic hypotension. J Clin Invest 35 (1956) 1412
18. Tsuneyoshi I., Yamada H., Kakihana Y., et al. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 29 (2001) 487
19. Bernadich C., Bandi J.C., and Bosch J. Effects of F-180, a new selective vasoconstrictor peptide compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension. Hepatology 27 (1998) 351
20. Westphal M., Stubbe H., Sielenkamper A.W., et al. Terlipressin response in healthy and endotoxinemic sheep: impact on cardiopulmonary performance and global oxygen. Intens Care Med 29 (2003) 301
21. Heyndrickx G.R., Boettcher D.H., and Vatner S.F. Effects of angiotensin, vasopressin and methoxamine on cardiac function and blood flow distribution in conscious dogs. Am J Phisiol 231 (1976) 1579-1587
22. Brackett D.J., Schaefer C.F., Tompkins P., et al. Evaluation of cardiac output, total peripheral resistances and plasma concentrations of vasopressin in the conscious, unrestrained rat during endotoxemia. Circ Shock 17 (1985) 273
23. Laszlo F., Karacsony G., Pavo I., et al. Aggressive role of vasopressin in development of different gastric lesions in rats. Eur J Pharmacol 258 (1994) 15